Competition studies of L1-deferiprone with copper and iron. Possible implications on efficacy, toxicity and new therapeutic applications.
Pashalidis
I
I
Department of Chemistry, University of Cyprus, Nicosia, Cyprus.
Kontoghiorghes
G J
GJ
D003300:Copper; D000077543:Deferiprone; D006801:Humans; D007501:Iron; D007502:Iron Chelating Agents / Q000494:pharmacology* / Q000627:therapeutic use; D019190:Iron Overload / Q000188:drug therapy*; D011728:Pyridones / Q000494:pharmacology* / Q000627:therapeutic use
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D003300:Copper; D007501:Iron